Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Isotretinoin treatment in Palestine shows poor adherence to guidelines, with common side effects and a need for better prescribing practices and patient education.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

Isotretinoin may reduce inflammation by increasing adiponectin and leptin levels.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Most patients on isotretinoin for acne experience mild, dose-related side effects, but the connection to depression or bowel disease is uncertain.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Isotretinoin was not effective in treating facial lichen planopilaris.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Severe digestive issues in DRESS need early endoscopy for better treatment.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

The FDA approved a new Pfizer drug for hair loss in teens.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

The rash resolved after stopping ponatinib.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.